Skip to the page

Data / Drug companies / Zydus Lifesciences Limited

Zydus Lifesciences Limited: 523 products in the FDA NDC directory, labeler code 70771

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Zydus Lifesciences Limited (labeler code 70771) lists 523 products in the FDA National Drug Code Directory, covering 184 finished drugs by generic name. By type: 523 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 1, 2026.

The request: Watch Zydus Lifesciences Limited (FDA labeler code 70771): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70771
Products in commercial distribution
523
Packages
1,373
Finished drugs by generic name
184
Prescription products
523
Over the counter products
0
Controlled substance products
Schedule IV 4, Schedule V 6
Flagged as original packager
468 of 468 products that carry the flag
Started marketing in the last 12 months
53
Products with a marketing end date set
2
Earliest marketing start
October 27, 2016
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)50596.6%
New drug applications (NDA)101.9%
Authorized generics (NDA)81.5%

Products by type

TypeProductsShare
Prescription drugs523100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Diltiazem hydrochloride1555
Estradiol1253
Minocycline hydrochloride1129
Isotretinoin1016
Sitagliptin and metformin hydrochloride108
Topiramate956
Selexipag93
Dexamethasone745
Chlorpromazine hydrochloride727
Amitriptyline hydrochloride635
Lamotirigine61
Lenalidomide619
Sitagliptin68
Trazodone hydrochloride639
Memantine hydrochloride636
Nifedipine638
Dasatinib618
Doxycycline663
Isosorbide dinitrate518
Verapamil hydrochloride546
Lurasidone hydrochloride528
Brivaracetam517
Gabapentin591
Valsartan and hydrochlorothiazide521
Metronidazole468
Vardenafil46
Mesalamine441
Candesartan cilexetil48
Azithromycin441
Emtricitabine and tenofovir disoproxil fumarate428
Atorvastatin calcium459
Eltrombopag411
Tofacitinib423
Fluconazole448
Esomeprazole magnesium477
Baclofen465
Fluphenazine hydrochloride429
Venlafaxine433
Valsartan438
Doxazosin428
Methylprednisolone431
Tadalafil454
Metoprolol succinate446
Acyclovir470
Haloperidol decanoate416
Perphenazine418
Nortriptyline hydrochloride429
Bosentan37
Oxybutynin36
Doxycycline hyclate361
Allopurinol354
Zonisamide322
Carbamazepine352
Bisoprolol fumarate and hydrochlorothiazide312
Ascorbic acid36
Rivastigmine311
Spironolactone345
Labetalol hydrochloride343
Clobetasol propionate340
Candesartan cilexetil and hydrochlorothiazide35
Triamterene and hydrochlorothiazide327
Deferasirox321
Erlotinib35
Venlafaxine hydrochloride348
Dapsone326
Nadolol317
Propafenone hydrochloride315
Oseltamivir phosphate337
Oxcarbazepine346
Sacubitril and valsartan329
Liothyronine sodium319
Cyanocobalamin325
Bumetanide342
Droxidopa315
Zinc sulfate37
Azathioprine319
Midodrine hydrochloride334
Tizanidine hydrochloride325
Methylene blue315
Pitavastatin calcium310
Ursodiol328
Teriflunomide217
Nateglinide29
Entecavir215
Cholestyramine214
Nitrofurantoin macrocrystals220
Ambrisentan213
Betamethasone dipropionate227
Leflunomide219
Erythromycin236
Febuxostat222
Triazolam29
Prochlorperazine maleate231
Mirabegron210
Varenicline211
Theophylline224
Sertraline hydrochloride255
Fluorescein28
Felbamate211
Fluocinonide225

Dosage forms

Dosage formProductsShare
Tablet16331.2%
Tablet, film coated10620.3%
Capsule509.6%
Tablet, extended release397.5%
Capsule, extended release336.3%
Injection183.4%
Injection, solution152.9%
Tablet, film coated, extended release132.5%
Cream122.3%
Patch, extended release91.7%
Patch81.5%
Powder, for suspension71.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tranexamic Acid70771-1989TabletGeneric drugs (ANDA)November 1, 2026
Romidepsin70771-1986KitGeneric drugs (ANDA)November 1, 2026
Mupirocin70771-1981CreamGeneric drugs (ANDA)October 10, 2026
Ammonium lactate70771-1988CreamGeneric drugs (ANDA)October 2, 2026
Tretinoin70771-1933CreamGeneric drugs (ANDA)October 1, 2026
Ascorbic acid70771-1945InjectionGeneric drugs (ANDA)September 28, 2026
Ascorbic acid70771-1944InjectionGeneric drugs (ANDA)September 28, 2026
Ascorbic acid70771-1943InjectionGeneric drugs (ANDA)September 28, 2026
Indocyanine green70771-1961KitGeneric drugs (ANDA)August 4, 2026
Fluvoxamine maleate extended-release70771-1958Capsule, extended releaseGeneric drugs (ANDA)August 4, 2026
Fluvoxamine maleate extended-release70771-1957Capsule, extended releaseGeneric drugs (ANDA)August 4, 2026
Sugammadex70771-1857Injection, solutionGeneric drugs (ANDA)July 2, 2026
Sugammadex70771-1856Injection, solutionGeneric drugs (ANDA)July 2, 2026
Tofacitinib70771-1967Tablet, film coatedGeneric drugs (ANDA)June 5, 2026
Fluorescein70771-1970InjectionGeneric drugs (ANDA)June 2, 2026
Fluorescein70771-1969InjectionGeneric drugs (ANDA)June 2, 2026
Diltiazem hydrochloride70771-1932TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride70771-1931TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride70771-1930TabletGeneric drugs (ANDA)May 25, 2026
Diltiazem hydrochloride70771-1929TabletGeneric drugs (ANDA)May 25, 2026
Verapamil hydrochloride70771-1955TabletGeneric drugs (ANDA)May 21, 2026
Verapamil hydrochloride70771-1954TabletGeneric drugs (ANDA)May 21, 2026
Verapamil hydrochloride70771-1953TabletGeneric drugs (ANDA)May 21, 2026
Tofacitinib70771-1628Tablet, film coated, extended releaseGeneric drugs (ANDA)May 20, 2026
Tofacitinib70771-1627Tablet, film coated, extended releaseGeneric drugs (ANDA)May 20, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.